Foscarnet.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000998:Antiviral Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000150:complications / Q000188:drug therapy*; D015828:Eye Infections, Viral / Q000150:complications / Q000188:drug therapy*; D017245:Foscarnet; D006801:Humans; D010746:Phosphonoacetic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D012173:Retinitis / Q000150:complications / Q000188:drug therapy* / Q000401:mortality
D000998:Antiviral Agents; D017245:Foscarnet; D010746:Phosphonoacetic Acid